Kazuki Sone

513 total citations
35 papers, 392 citations indexed

About

Kazuki Sone is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kazuki Sone has authored 35 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kazuki Sone's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). Kazuki Sone is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Research Studies (9 papers) and Drug Transport and Resistance Mechanisms (7 papers). Kazuki Sone collaborates with scholars based in Japan, France and United States. Kazuki Sone's co-authors include Akio Niimi, Yoshihiro Kanemitsu, Satoshi Fukuda, Hirotsugu Ohkubo, Guillaume Mestrallet, Masaya Takemura, Osamu Takakuwa, Yutaka Ito, Ken Maeno and Tetsuya Oguri and has published in prestigious journals such as Hepatology, Scientific Reports and Journal of Materials Chemistry A.

In The Last Decade

Kazuki Sone

34 papers receiving 387 citations

Peers

Countries citing papers authored by Kazuki Sone

Since Specialization

Citations

This map shows the geographic impact of Kazuki Sone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kazuki Sone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kazuki Sone more than expected).

Fields of papers citing papers by Kazuki Sone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kazuki Sone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kazuki Sone. The network helps show where Kazuki Sone may publish in the future.

Co-authorship network of co-authors of Kazuki Sone

This figure shows the co-authorship network connecting the top 25 collaborators of Kazuki Sone. A scholar is included among the top collaborators of Kazuki Sone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kazuki Sone. Kazuki Sone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages 2025 ·JCI Insight ·Takahiko Sato, Daisuke Sugiyama, Jun Koseki, Yasuhiro Kojima, (unknown), Kazuki Sone, Hitomi Nishinakamura, Tomohiro Ishikawa, Yuichi Ishikawa, (unknown), Hitoshi Kiyoi, Hiroyoshi Nishikawa	10
2	Observation of Collective Migration of Vascular Endothelial Cells Exposed to Lipopolysaccharide and Hypoxia 2025 ·PubMed ·Kazuki Sone, Keisuke Koba, (unknown), Kenichi Funamoto	0
3	Hypoxia suppresses glucose-induced increases in collective cell migration in vascular endothelial cell monolayers 2024 ·Scientific Reports ·Kazuki Sone, (unknown), (unknown), (unknown), Masanori Tachikawa, Daisuke Yoshino, Kenichi Funamoto	4
4	Oxoammonium salts exert antiviral effects against coronavirus via denaturation of their spike proteins 2024 ·Scientific Reports ·(unknown), Yusuke Sasano, (unknown), Yasuhiro Fujisawa, (unknown), Masanobu Uchimura, (unknown), Kotaro Matsumoto, Kazuki Sone, Tomoyuki Oe, Yoshiharu Iwabuchi, (unknown), Noriyasu Hirasawa	1
5	Differences in the Therapeutic Effect of Chemotherapy Regimens for Concurrent Chemoradiotherapy of Locally Advanced Non-small Cell Lung Cancer 2022 ·Anticancer Research ·(unknown), Tetsuya Oguri, Yusuke Kagawa, Kazuki Sone, Satoshi Fukuda, Takehiro Uemura, Osamu Takakuwa, Ken Maeno, (unknown), Yoshihiro Kanemitsu, Tomoko Tajiri, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Akio Niimi	1
6	Strategies to overcome DC dysregulation in the tumor microenvironment 2022 ·Frontiers in Immunology ·Guillaume Mestrallet, Kazuki Sone, Nina Bhardwaj	37
7	Genetic variations in the ATP-binding cassette transporter ABCC10 are associated with neutropenia in Japanese patients with lung cancer treated with nanoparticle albumin-bound paclitaxel 2022 ·Investigational New Drugs ·(unknown), Takehiro Uemura, Tetsuya Oguri, (unknown), Sayaka Yamamoto, Yuto Suzuki, Yusuke Kagawa, Kazuki Sone, Satoshi Fukuda, Yuta Mori, Kensuke Fukumitsu, Yoshihiro Kanemitsu, Tomoko Tajiri, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Ken Maeno, Akio Niimi	1
8	Predictive role of CYFRA 21-1 for S-1 monotherapy in non-small cell lung cancer patients 2022 ·Respiratory Investigation ·Yusuke Kagawa, Kazuki Sone, Tetsuya Oguri, (unknown), Satoshi Fukuda, Takehiro Uemura, Osamu Takakuwa, Ken Maeno, (unknown), Yoshihiro Kanemitsu, Tomoko Tajiri, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Akio Niimi	5
9	Effective 3D open-channel nanostructures of a MgMn₂O₄ positive electrode for rechargeable Mg batteries operated at room temperature 2021 ·Journal of Materials Chemistry A ·Kazuki Sone, Y. Hayashi, Toshihiko Mandai, Shunsuke Yagi, Yuya Oaki, Hiroaki Imai	23
10	Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort 2019 ·BMC Cancer ·Kazuki Sone, Tetsuya Oguri, Takehiro Uemura, Akira Takeuchi, Satoshi Fukuda, Osamu Takakuwa, Ken Maeno, Kensuke Fukumitsu, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Akio Niimi	23
11	ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5-fluorouracil derivative drug S-1 treatment in non-small cell lung cancer 2019 ·Cancer Chemotherapy and Pharmacology ·Takehiro Uemura, Tetsuya Oguri, Ken Maeno, Kazuki Sone, Akira Takeuchi, Satoshi Fukuda, (unknown), Osamu Takakuwa, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Akio Niimi	5
12	TTF-1 Expression Predicts the Merit of Additional Antiangiogenic Treatment in Non-squamous Non-small Cell Lung Cancer 2018 ·Anticancer Research ·Akira Takeuchi, Tetsuya Oguri, Yoriko Yamashita, Kazuki Sone, Satoshi Fukuda, Osamu Takakuwa, Takehiro Uemura, Ken Maeno, Kensuke Fukumitsu, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Akio Niimi	15
13	Predictive Role of CYFRA21-1 and CEA for Subsequent Docetaxel in Non-small Cell Lung Cancer Patients 2017 ·Anticancer Research ·Kazuki Sone, Tetsuya Oguri, (unknown), Yuki Kitamura, Yoshitsugu Inoue, Akira Takeuchi, Satoshi Fukuda, Osamu Takakuwa, Ken Maeno, Takamitsu Asano, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Akio Niimi	17
14	Osimertinib-induced interstitial lung disease in a patient with non-small cell lung cancer pretreated with nivolumab: A case report 2017 ·Molecular and Clinical Oncology ·Osamu Takakuwa, Tetsuya Oguri, Takehiro Uemura, Kazuki Sone, Satoshi Fukuda, (unknown), Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Ken Maeno, Akio Niimi	16
15	CYFRA 21-1 as a Predictive Marker for Non-small Cell Lung Cancer Treated with Pemetrexed-based Chemotherapy 2017 ·Anticancer Research ·Kazuki Sone, Tetsuya Oguri, Makoto Nakao, Yusuke Kagawa, (unknown), (unknown), Satoshi Fukuda, Takehiro Uemura, Osamu Takakuwa, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Ken Maeno, Yutaka Ito, H Sato, Hideki Muramatsu, Akio Niimi	25
16	Organic cation transporter 6 directly confers resistance to anticancer platinum drugs 2016 ·Biomedical Reports ·Tetsuya Oguri, (unknown), Satoshi Fukuda, Kazuki Sone, Takehiro Uemura, Osamu Takakuwa, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Ken Maeno, Yutaka Ito, Akio Niimi	17
17	Diagnostic delay of pulmonary tuberculosis in patients with acute respiratory distress syndrome associated with aspiration pneumonia: Two case reports and a mini-review from Japan 2016 ·Experimental and Therapeutic Medicine ·Makoto Nakao, Kazuki Sone, Yusuke Kagawa, (unknown), H Sato, (unknown), Hideki Muramatsu	5
18	A folylpoly-γ-glutamate synthase single nucleotide polymorphism associated with response to pemetrexed treatment combined with platinum for non-small cell lung cancer 2016 ·Lung Cancer ·Satoshi Fukuda, Tetsuya Oguri, (unknown), Kazuki Sone, Takehiro Uemura, Osamu Takakuwa, Ken Maeno, Yoshihiro Kanemitsu, Hirotsugu Ohkubo, Masaya Takemura, Yutaka Ito, Akio Niimi	11
19	Epidermal growth factor receptor-tyrosine kinase inhibitors for non-small-cell lung cancer patients aged 80 years or older: A retrospective analysis 2014 ·Molecular and Clinical Oncology ·Makoto Nakao, Hideki Muramatsu, Kazuki Sone, (unknown), (unknown), Yusuke Kagawa, H Sato, (unknown)	6
20	Measurement of .BETA.2-Microglobulin in Bovine Serum and Urine by Radioimmunoassay. 1996 ·Journal of Veterinary Medical Science ·(unknown), Nobuhiko Ito, (unknown), (unknown), Kazuki Sone, (unknown), Tadashi Saitoh, (unknown), Tohru Yamaguchi	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact